A PROSPECTIVE EVALUATION OF HEPATIC, SYSTEMIC AND PULMONARY HEMODYNAMICS IN HIV-HCV COINFECTED PATIENTS PRIOR AND AFTER ANTIVIRAL THERAPY

被引：0
|
作者：
Reiberger, T. [1 ]
Ferlitsch, A. [1 ]
Payer, B. A. [1 ]
Sieghart, W. [1 ]
Rieger, A. [2 ]
Peck-Radosavljevic, M. [1 ]
机构：
[1] Med Univ Vienna, Div Gastroenterol Hepatol, Vienna, Austria
[2] Med Univ Vienna, Div Immunol Allergy & Infect Dis, Vienna, Austria
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
10.1016/S0168-8278(11)61178-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1176
引用
收藏
页码：S464 / S465
页数：2
相关论文
共 50 条
  • [21] Liver transplantation for HCV cirrhosis in HIV-HCV coinfected patients. Evaluation of antiretroviral toxicity and of HCV recurrence.
    Samuel, D
    Vittecoq, D
    Duclos-Vallee, JC
    Feray, C
    Teicher, E
    Azoulay, D
    Saliba, F
    Afonso, AMR
    Ichai, P
    Castaing, D
    Adam, R
    Guettier, C
    Dussaix, E
    Bismuth, H
    HEPATOLOGY, 2002, 36 (04) : 231A - 231A
  • [22] Early plasma exposure after a first dose of ribavirin in HIV-HCV coinfected patients compared with HCV monoinfected patients
    Hatu, Giorgiana
    Pradat, Pierre
    Pourcelot, Emmanuel
    Maynard-Muet, Marianne
    Bailly, Francois
    Miailhes, Patrick
    Zoulim, Fabien
    Gagnieu, Marie-Claude
    HEPATOLOGY, 2013, 58 : 1134A - 1134A
  • [23] Antiviral treatment in HCV recurrence after liver transplantation in HCV-HIV coinfected patients
    Castells, LL
    Vargas, V
    Len, O
    Bilbao, I
    Margarit, C
    Pahissa, A
    Esteban, JI
    Esteban, R
    Guardia, J
    LIVER TRANSPLANTATION, 2005, 11 (07) : C77 - C77
  • [24] HCV viral recurrence and liver mitochondrial damage after liver transplantation (LT) in HIV-HCV coinfected patients
    Duclos-Vallee, JC
    Vittecoq, D
    Teicher, E
    Feray, C
    Roque-Afonso, AM
    Lombes, A
    Jardel, C
    Gigou, M
    Dussaix, E
    Guettier, C
    Sebagh, M
    Azoulay, D
    Adam, R
    Ichai, P
    Saliba, F
    Roche, B
    Castaing, D
    Samuel, D
    JOURNAL OF HEPATOLOGY, 2004, 40 : 44 - 44
  • [25] INFLUENCE OF PNPLA3 SNP ON HEPATIC STEATOSIS AND FIBROSIS PROGRESSION IN HIV-HCV COINFECTED PATIENTS
    Payer, B. A.
    Reiberger, T.
    Stift, J.
    Aichelburg, M. C.
    Breitenecker, F.
    Rieger, A.
    Peck-Radosavljevic, M.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S356 - S356
  • [26] A DESCRIPTION OF FIBROSING CHOLESTATIC HEPATITIS AFTER LIVER TRANSPLANTATION (LT) IN HIV-HCV COINFECTED PATIENTS
    Antonini, Teresa Maria
    Roque-Afonso, Anne-Marie
    Sebagh, Mylene
    Roche, Bruno
    Sobesky, Rodolphe
    Guettier, Catherine
    Samuel, Didier
    Duclos-Vallee, Jean-Charles
    HEPATOLOGY, 2008, 48 (04) : 582A - 582A
  • [27] Histological lesions and intrahepatic HCV detection in HIV-HCV coinfected patients, before and after anti-HCV treatment.
    Le Bail, B
    Rullier, A
    Trimoulet, P
    Neau, D
    Urbaniak, R
    Ballardini, G
    Lafon, ME
    Bioulac-Sage, P
    HEPATOLOGY, 2002, 36 (04) : 564A - 564A
  • [28] Liver fibrosis progression despite HCV cure with antiviral therapy in HIV-HCV-coinfected patients
    Labarga, Pablo
    Fernandez-Montero, Jose V.
    de Mendoza, Carmen
    Barreiro, Pablo
    Pinilla, Javier
    Soriano, Vincent
    ANTIVIRAL THERAPY, 2015, 20 (03) : 329 - 334
  • [29] NEUTROPENIA AND LOW CD4+CELL COUNTS DURING ANTIVIRAL THERAPY ARE NOT ASSOCIATED WITH INCREASED RISK OF INFECTIONS IN HIV-HCV COINFECTED PATIENTS
    Payer, Berit A.
    Reiberger, Thomas
    Breitenecker, Florian
    Rieger, Armin
    Peck-Radosavljevic, Markus
    HEPATOLOGY, 2011, 54 : 819A - 819A
  • [30] The Prevalence and Impact of Hepatic Steatosis on Response to Direct-Acting Antiviral Therapy in HIV-HCV Coinfection
    Johnson, Leigh P.
    Sterling, Richard K.
    BIOLOGY-BASEL, 2020, 9 (04):
12345